Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U - a Human Randomized Clinical Trial. Substudy.

NCT02975479 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02975479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02975479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U - a Human Randomized Clinical Trial. Substudy.
Lead sponsor
Karolinska Institutet
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2016
Completion date
June 20, 2022
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, allergic, seasonal